Clinical Observation Of Koumiss Therapy To The Treatment For Constipation After SA Disease

Objective:Through the use of Koumiss therapy to treat patients with constipation after SA disease,and compared with western medicine Lactulose Oral Liquid,observation and analysis before and after treatment of constipation symptoms,quality of life,Barthel index,to explore the clinical curative effect,for clinical treatment to provide new ideas for the treatment of constipation after SA disease.Methods:This study selected between December 2020 and December 2021,in the Inner Mongolia Minzu University affiliated hospital rehabilitation care hospital diagnosed as Mr Source of 60 cases of cases of constipation after illness,treatment group 30 cases were randomly divided into policy,therapy,and the control group of 30 cases of oral lactulose oral solution,2 groups of patients were treated 14 days.Symptom score,PAC-QOL Quality of Life Scale and MBI scale were used to evaluate the efficacy,and the collected data were statistically analyzed.Results:1.Before treatment,the constipation symptoms,quality of life and MBI scores of the two groups were compared between the two groups.The differences were not statistically significant(p>0.05).2.Before and after treatment,constipation symptoms,PAC-QOL score and MBI score were compared between the two groups,and the differences were statistically significant(P<0.05).3.After treatment,the two groups were compared between the two groups,constipation symptoms and MBI scores showed statistical differences after treatment(P<0.05);There was no significant difference in PAC-QOL score(P>0.05).Among the main symptoms of constipation,there were statistically significant differences in defecation difficulty,feeling of falling and abdominal distension score(P<0.05),while there were no statistically significant differences in defecation time,fecal traits and defecation frequency score(P>0.05)..There were statistically significant differences in the scores of anorexia,dry mouth and deficiency of fluid in secondary symptoms of constipation(P<0.01),but there were no statistically significant differences in scores of mental fatigue and limb weakness(P>0.05).4.Comparison of efficacy: the total effective rate of the observation group was86.7%,and the total effective rate of the control group was 73.3%,with statistical difference between the two groups(P<0.05).Conclusion:Koumiss therapy can obviously improve the constipation symptoms of patients with constipation after SA disease,especially better than lactulose oral solution in improving defecation difficulty,feeling of falling down,abdominal distention,loss of appetite,dry mouth and less fluid.Koumiss therapy was superior to lactilose oral solution in improving the ability of daily living,while the efficacy of Koumiss therapy was similar to that of lactilose oral solution in improving the quality of life of constipation patients.Koumiss therapy has no adverse reaction,good safety and definite curative effect in the treatment of constipation after SA disease,which is worthy of clinical promotion.